Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paradigm is a specialty care management company focused on improving outcomes for people with complex injuries and diagnoses, primarily in workers' compensation and increasingly in broader healthcare markets. The business is best known for catastrophic care management, case management, specialty networks, home health, payment integrity, and shared decision support offerings delivered through a value-based, outcomes-driven model. Rather than developing therapeutics, Paradigm manages high-acuity and high-cost cases such as traumatic brain injuries, spinal cord injuries, burns, amputations, chronic pain, and musculoskeletal injuries. The requested name, "Paradigm Catastrophic Care Management," refers to a major business unit and service line within Paradigm rather than a separate drug-development biotech company. As of 2026, Paradigm remains active and has signed a definitive agreement to be acquired by Patient Square Capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paradigm Catastrophic Care Management.